APA (7th ed.) Citation

Ravish H S, Akash Khobragade, Durga Satapathy, Monica Gupta, Surendra Kumar, Vinay Bhomia, . . . Ashok Dilipkumar Agrawal. (2021). Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Ravish H S, Akash Khobragade, Durga Satapathy, Monica Gupta, Surendra Kumar, Vinay Bhomia, Ramasubramanian V, Maharshi Desai, and Ashok Dilipkumar Agrawal. Safety and Immunogenicity of a Novel Three-dose Recombinant Nanoparticle Rabies G Protein Vaccine Administered as Simulated Post Exposure Immunization: A Randomized, Comparator Controlled, Multicenter, Phase III Clinical Study. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Ravish H S, et al. Safety and Immunogenicity of a Novel Three-dose Recombinant Nanoparticle Rabies G Protein Vaccine Administered as Simulated Post Exposure Immunization: A Randomized, Comparator Controlled, Multicenter, Phase III Clinical Study. Taylor & Francis Group, 2021.